COLORADO SPRINGS, Colo., The Spectranetics Corporation today announced U.S. Food and Drug Administration (FDA) Premarket Notification 510(k) submission of the Bridge Occlusion Balloon. Building on the ...
The Spectranetics Corp. said it received clearance of its bridge occlusion balloon for temporary vessel occlusion in cardiac lead extraction procedures. The Colorado Springs, Colorado-based company ...
COLORADO SPRINGS, Colo., Jul 01, 2010 (BUSINESS WIRE) -- Spectranetics Corporation /quotes/comstock/15*!spnc/quotes/nls/spnc (SPNC 5.19, +0.03, +0.58%) today ...
The U.S. FDA’s final guidance for clinical decision support (CDS) systems may be the subject of two citizen’s petitions requesting the agency scrap the guidance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results